MTOR and metastatic malignant neoplasm in the lymph nodes: Yu et al (31) demonstrated that mTOR overexpression was associated with high and moderate differentiation, T1/T2 tumors and stage I/II disease, whereas pmTOR overexpression was found to correlate with lymph node metastasis and advanced-stage disease, and may present an independent predictor of gastric cancer survival.